The membrane matters: Plasma membrane composition shapes MRGPRX2-driven immune responses

Abstract

The composition and biophysical characteristics of the plasma membrane are pivotal in regulating mast cell immune functions by influencing receptor distribution, activation, and intracellular signaling pathways. This article highlights the impact of plasma membrane components, such as cholesterol and lipid rafts, on the function of the Mas-related G protein-coupled receptor X2 (MRGPRX2), a key mediator of IgE-independent mast cell activation and pseudoallergic reactions. We discuss how variations in membrane fluidity, lipid composition, and microdomain organization influence MRGPRX2 conformational dynamics, ligand accessibility, and downstream signaling efficiency. These membrane-driven effects may help explain the heterogeneity of mast cell responsiveness across tissues and disease states. Integrating insights from structural biology, biophysics, and clinical immunology emphasizes that plasma membrane composition and dynamics regulate MRGPRX2-mediated signaling, positioning the membrane environment as a promising therapeutic target for modulating mast-cell hyperreactivity. By outlining this conceptual framework, we introduce a unifying hypothesis that membrane-driven regulation is a critical, yet underrecognized, determinant of MRGPRX2 responsiveness in different tissues and disease states.

Keywords

MRGPRX2 / plasma membrane fluidity / skin inflammatory diseases

References

[1] McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, et al. Identification of a mast—cell—specific receptor crucial for pseudo—allergic drug reactions. Nature. 2015; 519:237-41.

[2] Castells M, Madden M, Oskeritzian CA. Mast Cells and Mas—related G Protein—coupled Receptor X2: Itching for Novel Pathophysiological Insights to Clinical Relevance. Curr Allergy Asthma Rep. 2025; 25:5.

[3] Escribá PV, Busquets X, Inokuchi J, Balogh G, Török Z, Horváth I, et al. Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Prog Lipid Res. 2015; 59:38-53.

[4] Okayama Y, Saito H, Ra C. Targeting human mast cells expressing g—protein—coupled receptors in allergic diseases. Allergol Int. 2008; 57:197-203.

[5] Fallahi—Sichani M, Linderman JJ . Lipid raft—mediated regulation of G—protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One. 2009; 4:e6604.

[6] Roy S, Chompunud Na Ayudhya C, Thapaliya M, Deepak V, Ali H. Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease. J Allergy Clin Immunol. 2021; 148:293-308.

[7] Lerner L, Babina M, Zuberbier T, Stevanovic K. Beyond Allergies—Updates on The Role of Mas—Related G—Protein—Coupled Receptor X2 in Chronic Urticaria and Atopic Dermatitis. Cells. 2024; 13:220.

[8] Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, Furuno M, et al. Immunoglobulin E—independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun. 2006; 349:1322—8.

[9] Lazki—Hagenbach P, Kleeblatt E, Ali H, Sagi—Eisenberg R. Spatiotemporal Patterns of Substance P—Bound MRGPRX2 Reveal a Novel Connection Between Macropinosome Resolution and Secretory Granule Regeneration in Mast Cells. Front Immunol. 2022; 13:892239.

[10] Grimes J, Desai S, Charter NW, Lodge J, Moita Santos R, Isidro—Llobet A, et al. MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo—allergic and anaphylactoid reactions. Pharmacol Res Perspect. 2019; 7:e00547.

[11] Maier P, Macht M, Beck S, Kolkhir P, Babina M, Kremer AE, et al. MRGPRX2 ligandome: Molecular simulations reveal three categories of ligand—receptor interactions. J Struct Biol. 2025; 217:108193.

[12] Li Z, Schneikert J, Bal G, Zuberbier T, Babina M. Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast Cells. Biomolecules. 2025; 15:1224.

[13] Nagamine M, Kaitani A, Izawa K, Ando T, Yoshikawa A, Nakamura M, et al. Neuronal substance P—driven MRGPRX2—dependent mast cell degranulation products differentially promote vascular permeability. Front Immunol. 2024; 15:1477072.

[14] Baccouch R, Rascol E, Stoklosa K, Alves ID. The role of the lipid environment in the activity of G protein coupled receptors. Biophys Chem. 2022; 285:106794.

[15] Horváth Á, Erostyák J, Szőke É. Effect of Lipid Raft Disruptors on Cell Membrane Fluidity Studied by Fluorescence Spectroscopy. Int J Mol Sci. 2022; 23:13729.

[16] Chompunud Na Ayudhya C, Roy S, Alkanfari I, Ganguly A, Ali H. Identification of Gain and Loss of Function Missense Variants in MRGPRX2’s Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P. Int J Mol Sci. 2019; 20:5247.

[17] Fantini J, Di Scala C, Evans LS, Williamson PT, Barrantes FJ. A mirror code for protein—cholesterol interactions in the two leaflets of biological membranes. Sci Rep. 2016; 6:21907.

[18] Jakubík J, El—Fakahany EE. Allosteric Modulation of GPCRs of Class A by Cholesterol. Int J Mol Sci. 2021; 22:1953.

[19] Oates J, Watts A. Uncovering the intimate relationship between lipids, cholesterol and GPCR activation. Curr Opin Struct Biol. 2011; 21:802-7.

[20] Fantini J, Epand RM, Barrantes FJ. Cholesterol—Recognition Motifs in Membrane Proteins. In: Rosenhouse—Dantsker A, Bukiya AN, editors. Direct Mechanisms in Cholesterol Modulation of Protein Function. Cham: Springer International Publishing; 2019. pp. 3-25.

[21] West PW, Chéret J, Bahri R, Kiss O, Wu Z, Macphee CH, et al. The MRGPRX2—substance P pathway regulates mast cell migration. iScience. 2024; 27:110984.

[22] Marguet D, Lenne PF, Rigneault H, He HT. Dynamics in the plasma membrane: how to combine fluidity and order. EMBO J. 2006; 25:3446—57.

[23] Rong X, Albert CJ, Hong C, Duerr MA, Chamberlain BT, Tarling EJ, et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab. 2013; 18:685-97.

[24] Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, et al. Structure, function and pharmacology of human itch GPCRs. Nature. 2021; 600:170—5.

[25] Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, et al. Structure, function and pharmacology of human itch receptor complexes. Nature. 2021; 600:164-9.

[26] Wheatley M, Wootten D, Conner MT, Simms J, Kendrick R, Logan RT, et al. Lifting the lid on GPCRs: the role of extracellular loops. Br J Pharmacol. 2012; 165:1688-703.

[27] Guo L, Zhang Y, Fang G, Tie L, Zhuang Y, Xue C, et al. Ligand recognition and G protein coupling of the human itch receptor MRGPRX1. Nat Commun. 2023; 14:5004.

[28] Chachisvilis M, Zhang YL, Frangos JA. G protein—coupled receptors sense fluid shear stress in endothelial cells. Proc Natl Acad Sci U S A. 2006; 103:15463—8.

[29] Ogasawara H, Noguchi M. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells. Cells. 2021; 10:2906.

[30] Al Hamwi G, Alnouri MW, Verdonck S, Leonczak P, Chaki S, Frischbutter S, et al. Subnanomolar MAS—related G protein—coupled receptor—X2/B2 antagonists with efficacy in human mast cells and disease models. Signal Transduct Target Ther. 2025; 10:128.